SLC3A2 and neoplasm: Then, we analyzed the correlation between SLC3A2 expression and 60 immune check-point genes (Supplementary Figure S6A), of which 24 were stimulatory, like ICOS and CD28, while the other 36 genes were inhibitory for anti-tumor immunity, such as PD1 and PDL1 (CD274).